WASHINGTON, Jan 19 (Reuters) - The U.S. Food and Drug Administration has warned Daiichi Sankyo Co Ltd. (4568.T: Quote, NEWS , Research) about misleading promotional materials for its dry mouth drug Evoxac, according to an agency letter released on Friday.
